Related Experiment Videos
Secondary prevention of coronary heart disease
1Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303, USA.
Insights
Managing atherosclerotic coronary heart disease (CHD) risk factors significantly reduces mortality and improves patient quality of life. Multifactorial risk reduction offers the greatest benefits for cardiovascular health.
Area of Science:
- Cardiology
- Public Health
Background:
- Atherosclerotic coronary heart disease (CHD) remains a primary cause of death in the US despite declining cardiovascular mortality.
- Risk factor modification is proven effective in reducing mortality and morbidity in patients with CHD.
Purpose of the Study:
- To emphasize the importance of multifactorial coronary risk reduction in managing patients with CHD.
- To highlight the benefits of controlling coronary risk factors for patient outcomes.
Main Methods:
- Review of randomized clinical trials and evidence on risk factor modification in CHD patients.
- Analysis of outcomes associated with multifactorial coronary risk reduction strategies.
Main Results:
- Multifactorial risk reduction yields substantial benefits for patients with CHD.
- Coronary risk reduction leads to fewer hospital admissions and revascularization procedures.
- Improved quality of life is observed in patients undergoing comprehensive risk factor control.
Conclusions:
- Control of coronary risk factors is essential for optimal patient care in CHD.
- Aggressive risk factor management improves survival and reduces healthcare utilization in CHD patients.
Abstract:
Despite the significant reduction in cardiovascular mortality during the past three decades, atherosclerotic coronary heart disease (CHD) remains the leading cause of death and disability in the United States. Randomized clinical trials in patients with CHD have provided convincing evidence that risk factor modification is beneficial in decreasing all-cause mortality and cardiovascular morbidity and mortality. Multifactorial coronary risk reduction provides the most substantial benefit. Coronary risk reduction is associated with a decrease in cardiovascular-related hospital admissions, a reduced need for myocardial revascularization procedures, and an improved quality of life for the patients so treated. Control of coronary risk factors is an integral component of the optimal care of the patient with CHD.